Search Results 1151-1160 of 16418 for monoclonal antibody

  1. Publications - Saad J. Kenderian, M.B., Ch.B. - Mayo Clinic

    Zirconium- 89 Labeled Antibody K1-70 for PET ... Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic ...

  2. Anand Padmanabhan, M.B.B.S., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    ... (monoclonal gammopathy of thrombotic/thrombocytopenic significance). ... MemberThe Antibody Society. 2021 - present. FacultyDLMP Research Strategy: Mentoring ...

  3. 177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancer - Mayo Clinic

    ), immunotherapy or biological therapy [including monoclonal antibodies]) [Note: Taxane exposure (maximum 6 cycles) in the adjuvant or neoadjuvant setting ...

  4. Brandon Wilbanks: Finding DNA Molecules That Can Transport Drugs Inside Cells - Student Research - Mayo Clinic College of Medicine & Science

    ... antibodies to cells ultimately may expand the potential targets for antibody drugs. Confocal microscopy image by Brandon Wilbanks Fluorescently labeled ...

  5. Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol - Mayo Clinic

    ... antibodies in your blood samples. The biomarker and antibody results along with your personal medical profile will be evaluated to determine your risk for ...

  6. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

    At any time received any monoclonal antibody (including biosimilars) targeting TNFα, IL-12, or IL-23, or anti-integrin agents approved for CD (i.e. ...

  7. Antithymocyte globulin rabbit (intravenous route) - Mayo Clinic

    Anti-thymocyte globulin (rabbit) injection is used together with other medicines to prevent and treat the body from rejecting a transplanted kidney. This ...

  8. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

    Secondary or familial amyloidosis; · Life expectancy of < 3 months; · Symptomatic multiple myeloma; · Hypersensitivities to other monoclonal antibodies; · Known HIV ...

  9. Mayo Clinic Research

    ... antibodies. Upon pathogen challenge or immunization, the elderly often demonstrate poor germinal center production, which leads to reduced antibody generation.

  10. An Efficacy Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    Treatment with any investigational products or with chimeric or fully human monoclonal antibodies within 30 days before randomization, systemic anticancer ...